These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4478937)

  • 21. Effects of the synalbumin insulin antagonist in vivo; its examination with a new method.
    Kammerer L; Bretán M; Steingaszner O
    Diabetologia; 1970 Oct; 6(5):473-4. PubMed ID: 5474812
    [No Abstract]   [Full Text] [Related]  

  • 22. [Insulin-inhibiting action of albumin obtained from serum of patients with diabetes and coronary sclerosis].
    Kammerer L; Bretán M; Nemesánszky L; Virág S; Jakab L
    Orv Hetil; 1967 Jun; 108(25):1158-61. PubMed ID: 4965654
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibitory effect of a human serum albumin fraction on insulin activity.
    Koyama T; Miyamura K; Mizoguchi T
    Wakayama Med Rep; 1968 Mar; 12(4):193-204. PubMed ID: 5659919
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of synalbumin of lipolysis.
    Biener J; Vallance-Owen J
    Lancet; 1969 Dec; 2(7635):1390-2. PubMed ID: 4188277
    [No Abstract]   [Full Text] [Related]  

  • 25. Maternal synalbumin antagonism and large babies.
    Vallance-Owen J; McMaster D; Bajaj JS
    Lancet; 1973 Aug; 2(7825):358-9. PubMed ID: 4124531
    [No Abstract]   [Full Text] [Related]  

  • 26. Variations in synalbumin insulin antagonism during glucose-tolerance tests.
    Jervell J; Vallance-Owen J
    Lancet; 1967 Jun; 1(7502):1253-4. PubMed ID: 4165040
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new method of studying synalbumin insulin antagonist].
    Kammerer L; Bretán M; Steingaszner O
    Orv Hetil; 1970 Jun; 111(25):1454-5. PubMed ID: 5454030
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac infarction and insulin antagonism.
    VALLANCE-OWEN J; ASHTON WL
    Lancet; 1963 Jun; 1(7293):1226-8. PubMed ID: 13995893
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetic neuropathy--clinical and electrophysiological study in synalbumin positive and synalbumin negative subjects.
    Chopra JS; Connon JJ; Banerji NK
    Diabetologia; 1969 Dec; 5(6):413-5. PubMed ID: 5372894
    [No Abstract]   [Full Text] [Related]  

  • 30. Synalbumin insulin antagonism in idiopathic hypoglycemia of infancy.
    Sherman L; Rosenbloom AL
    Diabetes; 1968 Sep; 17(9):557-9. PubMed ID: 5675315
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetes mellitus and insulin antagonists].
    JERVELL J
    Nord Med; 1963 Jan; 69():55-8. PubMed ID: 13957696
    [No Abstract]   [Full Text] [Related]  

  • 32. The Vallance-Owen ("synalbumin") insulin antagonist. Reproducibility and reliability of results in nondiabetic and diabetic humans.
    Sherman L
    Diabetes; 1966 Mar; 15(3):149-59. PubMed ID: 5909494
    [No Abstract]   [Full Text] [Related]  

  • 33. The nature of the artifactual synalbumin insulin antagonist.
    Holcomb GN; Dulin WE
    Diabetologia; 1973 Dec; 9(6):509-13. PubMed ID: 4773552
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin antagonism in human serum.
    Pozza G; Ghidoni A
    Lancet; 1968 Oct; 2(7572):831. PubMed ID: 4175626
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin-like effects of puromycin on lactate metabolism in frog skeletal muscle.
    Gourley DR; Brunton LL
    Biochim Biophys Acta; 1969 Jun; 184(1):43-7. PubMed ID: 5791115
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the mechanism of insulin antagonism by albumin in rat diaphragm.
    Davidson MB; Goodner CJ
    Diabetes; 1966 Jun; 15(6):373-9. PubMed ID: 5937206
    [No Abstract]   [Full Text] [Related]  

  • 37. [INSULIN ANTAGONISTS].
    VALLANCE-OWEN J
    Clin Ter; 1964 Aug; 30():308-13. PubMed ID: 14187104
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin antagonism in serum of untreated diabetics and in previously treated diabetics with ketoacidosis.
    GUNDERSEN K; WILLIAMS RH
    Proc Soc Exp Biol Med; 1960 Nov; 105():390-3. PubMed ID: 13709767
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of tolbutamide and insulin on insulin inhibitory activity associated with plasma albumin.
    Devrim S; Kilo C; Voyles N; Recant L
    Diabetes; 1968 Dec; 17(12):746-51. PubMed ID: 5726254
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasmatic factors of insulin antagonism in the diabetic subject].
    RODARI T; SPECCHIA G
    Folia Endocrinol Mens Incretologia Incretoterapia; 1961 Feb; 14():88-93. PubMed ID: 13742501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.